QualityStocksNewsBreaks Archives - Page 316 of 1457

TuesdayMay 09, 2023 2:46 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Awarded U.S. Patent Protecting Ongoing R&D of Therapeutic for Stress-Induced Affective Disorder and Alzheimer’s Disease

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has received a patent from the U.S. Patent and Trademark Office (“USPTO”). Titled “Biomarkers for Efficacy of Prophylactic Treatments Against Stress-Induced Affective Disorders,” the patent claims cover the use of biomarkers in determining the efficacy of SILO’s portfolio drug SPC-15. SPC-15 is a targeted prophylactic treatment that uses ketamine compositions as a key component for treating stress-induced affective disorder or stress-induced psychopathology. According to the announcement, the company owns an option to license specific assets of which the patent forms a part. SPC-15…

TuesdayMay 09, 2023 2:26 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Doses Last Subject in Phase 1, Part B CYB004-E Trial

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, has completed dosing in part b of its three-part CYB004-E phase 1 trial. The study is designed to evaluate intravenous N,N-dimethyltryptamine (“IV DMT”) in healthy volunteers. The company also announced that it now plans to move forward with part C of the study, which involves the first-in-human dosing of its proprietary DMT molecule CYB004 and will evaluate IV bolus + infusion regimens of CYB004 in a crossover design. The company expects that findings from both parts of the…

TuesdayMay 09, 2023 1:57 pm

QualityStocksNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Announces Q1 2023 Results

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) yesterday reported its first quarter (Q1) results for the period ended March 31, 2023. “This quarter we completed a series of large financing transactions involving shares of our McEwen Copper subsidiary, which has increased the market value attributable to our copper business to $550 million (for 100%) from $257 million at the conclusion of the prior financing round in August 2022. As 52% owner, McEwen Mining shareholders are benefitting from this value accretion, which validates the strategy we set out in July 2021 to surface value from Los Azules by funding it independently,”…

TuesdayMay 09, 2023 12:43 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Participation at Upcoming Needham Technology & Media Conference

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and the only provider building both annealing and gate-model quantum computers, today announced that Dr. Alan Baratz, CEO, and John Markovich, CFO, will present at the 18th Annual Needham Technology & Media Conference in New York City at 11 a.m. ET on Wednesday, May 17. Interested parties should visit https://ibn.fm/fAibm to register and listen to the investor presentation live via webcast. In addition, the archived webcast will be available on D-Wave’s Investor Relations page following the event. To view the full press release, visit https://ibn.fm/FpkpH About D-Wave Quantum…

MondayMay 08, 2023 3:00 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement, the study is the result of the focus Lexaria has had for years on oral nicotine formulations as an alternative to vaping or smoking; the company noted that results from the study could lead to more rapid commercial adoption and distribution of its patented DehydraTECH(TM) absorption technology, which is designed to improve oral uptake. Statistics show that some 7 million people die every year from cigarette smoking, and alternatives for nicotine delivery…

MondayMay 08, 2023 2:04 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Focuses on Growing Investor Relations through Transcend Collaboration

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, has announced a new collaboration with Transcend Capital Inc.; the partnership will be focused on growing FuelPositive’s investor relations and communications services throughout Canada. Transcend is a Vancouver-based, full-service investor relations company that has built a reputation for its successful market awareness campaigns that support micro, small and mid-cap public companies in efforts to gain industry exposure through its extensive network of retail and institutional clients. In addition, FuelPositive announced that Transcend principal Etienne Moshevich will perform shareholder communications services and serve as a key point of contact between Canadian…

MondayMay 08, 2023 2:00 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Discontinues Alliance with Mexico-Based Freight Company

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App offers a real-time portal for business-to-business (“B2B”) cross-border shipping and domestic shipping within the USMCA region, has discontinued its alliance with Zaro Transportation. Fr8App is an industry-leading freight-matching platform powered by AI and machine-learning. “At Fr8Tech, we entered into the strategic alliance with Zaro expecting to be able to reach a certain level of sales at margins that we expected would be lower than our other business segments but at acceptable levels,” said Fr8App CEO Javier Selgas in the press release. “Our alliance with Zaro enhanced Zaro’s ability to provide…

MondayMay 08, 2023 1:55 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Board Appointment of Pharma and Biotech Industry Veteran Dr. Bettina M. Cockroft

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its appointment of Bettina M. Cockroft, M.D., M.B.A., to its board of directors. Dr. Cockroft, a well-established industry executive with over 30 years of experience in the biopharmaceutical industry with clinical development expertise across multiple therapeutic areas, will serve as an independent director. “On behalf of the CNS Pharmaceuticals board and management, we are thrilled to welcome Dr. Cockroft to the board. Her appointment adds deep scientific, clinical and operational expertise, and…

MondayMay 08, 2023 12:51 pm

QualityStocksNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Issues Exploration Update for Stock Property

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) today reported assay results from three zones at the Stock Property, part of the Fox Complex near Timmins. According to the update, results from eight near-surface holes close to high-grade intersections in hole SM22-110 that included 264.5 g/t gold (Au) over 2.7 meters (m) returned attractive grades up to 18.9 g/t Au over 9.4 m. Drill holes were also completed in the lower portion of the Stock Mine Extension Trend, where recent deeper drilling was designed to expand lenses of mineralization in proximity to the Stock Mine. The lenses could represent early mining…

Site Search

Company Search

Category: QualityStocksNewsBreaks